Showing results (61-70 of 106) with videos related to
Sort By:
Pageof 11
Theranostics|January 22, 2019
An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potencyChenguang Shen, Minwei Zhang, Yuanzhi Chen, et al.Structure (London, England : 1993)|June 9, 2016
The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host InteractionZhihai Li, Xiaodong Yan, Hai Yu, et al.Journal of Virology|February 23, 2023
Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16Jie Chen, Daning Wang, Zhiping Wang, et al.Journal of Nanobiotechnology|January 19, 2025
Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sitesCiying Qian, Jie Chen, Yurou Yang, et al.Science Bulletin|December 30, 2023
Rational design of a cross-type HPV vaccine through immunodominance shift guided by a cross-neutralizing antibodyZhiping Wang, Daning Wang, Jie Chen, et al.Nature Communications|December 19, 2018
Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificityZhihai Li, Shuo Song, Maozhou He, et al.Nature Communications|June 22, 2026
Molecular basis of host ATP level modulation by actin-dependent secreted bacterial ATPase and its metaeffectorHongxin Guan, Yu Li, Luhao Zhang, et al.Journal of Virology|January 21, 2021
Structural basis for the shared neutralization mechanism of three classes of human papillomavirus type 58 antibodies with disparate modes of bindingMaozhou He, Xin Chi, Zhenghui Zha, et al.NPJ Vaccines|November 1, 2022
Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70Ciying Qian, Yurou Yang, Qin Xu, et al.Iscience|November 28, 2025
An engineered VSV-vectored rabies vaccine with an RABV-G-L71S mutationMingxi Yue, Yuhe Zhu, Hongchao Wu, et al.Pageof 11